Search - tctmd.com

Displaying 21 - 40 of 2154

Sort: Relevancy | Date

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

News Daily News

High Aerobic Fitness Linked to Less Chronic Disease in Later Life

Michael O'Riordan

October 10, 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

News Conference News EACTS 2025

SAVR Bests TAVI for 5-Year Survival in Combined RCT, Observational Data

Yael L. Maxwell

October 10, 2025

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

October 08, 2025

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

News Daily News

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

October 07, 2025

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

News Daily News

Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS

October 03, 2025

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

October 02, 2025

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

News Daily News

Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s

Michael O'Riordan

September 18, 2025

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

News Daily News

Half of Patients Stop Semaglutide for Weight Loss by 1 Year

September 18, 2025

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

ALONE-AF: Less Bleeding When OAC Stopped After Successful Ablation

News Conference News ESC 2025

ALONE-AF: Less Bleeding When OAC Stopped After Successful Ablation

September 08, 2025

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

News Daily News

Early TAVI Valve Deterioration More Likely in Younger Patients, Smaller Annuli

Yael L. Maxwell

September 04, 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

News Conference News ESC 2025

PARACHUTE-HF: Sacubitril/Valsartan Effective in Neglected Chagas Cardiomyopathy

Michael O'Riordan

September 01, 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

September 01, 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

September 01, 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

News Conference News ESC 2025

Vericiguat Misses Mark in Stable, Well-Treated HFrEF Patients: VICTOR

Michael O'Riordan

August 31, 2025

Starting SGLT2 inhibitors in the Hospital for Acute HF Gains Support

News Conference News ESC 2025

Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support

August 30, 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.